Detalhe da pesquisa
1.
The HIV-1 Viral Protease Is Activated during Assembly and Budding Prior to Particle Release.
J Virol
; 96(9): e0219821, 2022 05 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35438536
2.
COVID-19 and Cardiovascular Disease: From Bench to Bedside.
Circ Res
; 128(8): 1214-1236, 2021 04 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-33856918
3.
Global phosphoproteomics of CCR5-tropic HIV-1 signaling reveals reprogramming of cellular protein production pathways and identifies p70-S6K1 and MK2 as HIV-responsive kinases required for optimal infection of CD4+ T cells.
Retrovirology
; 15(1): 44, 2018 07 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29970186
4.
HIV signaling through CD4 and CCR5 activates Rho family GTPases that are required for optimal infection of primary CD4+ T cells.
Retrovirology
; 14(1): 4, 2017 01 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-28114951
5.
A Targeted Mass Spectrometry Assay for Detection of HIV Gag Protein Following Induction of Latent Viral Reservoirs.
Anal Chem
; 89(10): 5325-5332, 2017 05 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-28467046
6.
CD4+ memory stem cells are infected by HIV-1 in a manner regulated in part by SAMHD1 expression.
J Virol
; 88(9): 4976-86, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24554663
7.
The histone deacetylase inhibitor vorinostat (SAHA) increases the susceptibility of uninfected CD4+ T cells to HIV by increasing the kinetics and efficiency of postentry viral events.
J Virol
; 88(18): 10803-12, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25008921
8.
Central memory CD4+ T cells are preferential targets of double infection by HIV-1.
Virol J
; 12: 184, 2015 Nov 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-26559763
9.
Transmitted/founder and chronic subtype C HIV-1 use CD4 and CCR5 receptors with equal efficiency and are not inhibited by blocking the integrin α4ß7.
PLoS Pathog
; 8(5): e1002686, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22693444
10.
Multifaceted mechanisms of HIV inhibition and resistance to CCR5 inhibitors PSC-RANTES and Maraviroc.
Antimicrob Agents Chemother
; 57(6): 2640-50, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23529732
11.
Engineering HIV-resistant human CD4+ T cells with CXCR4-specific zinc-finger nucleases.
PLoS Pathog
; 7(4): e1002020, 2011 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-21533216
12.
Phenotypic and immunologic comparison of clade B transmitted/founder and chronic HIV-1 envelope glycoproteins.
J Virol
; 85(17): 8514-27, 2011 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-21715507
13.
Primary infection by a human immunodeficiency virus with atypical coreceptor tropism.
J Virol
; 85(20): 10669-81, 2011 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-21835785
14.
Molecular mechanisms of HIV entry.
Adv Exp Med Biol
; 726: 223-42, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22297516
15.
HIV-1 resistance to CCR5 antagonists associated with highly efficient use of CCR5 and altered tropism on primary CD4+ T cells.
J Virol
; 84(13): 6505-14, 2010 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-20410277
16.
A maraviroc-resistant HIV-1 with narrow cross-resistance to other CCR5 antagonists depends on both N-terminal and extracellular loop domains of drug-bound CCR5.
J Virol
; 84(20): 10863-76, 2010 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-20702642
17.
Extracellular vesicles carry SARS-CoV-2 spike protein and serve as decoys for neutralizing antibodies.
J Extracell Vesicles
; 10(8): e12112, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34188786
18.
Comparisons of CD8+ T cells specific for human immunodeficiency virus, hepatitis C virus, and cytomegalovirus reveal differences in frequency, immunodominance, phenotype, and interleukin-2 responsiveness.
J Virol
; 83(6): 2728-42, 2009 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-19129459
19.
Nanoscale flow cytometry reveals interpatient variability in HIV protease activity that correlates with viral infectivity and identifies drug-resistant viruses.
Sci Rep
; 10(1): 18101, 2020 10 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-33093566
20.
Human immunodeficiency virus viremia induces plasmacytoid dendritic cell activation in vivo and diminished alpha interferon production in vitro.
J Virol
; 82(8): 3997-4006, 2008 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-18256146